Zhiqiang Shu
Stock Analyst at Berenberg
(0.12)
# 4,105
Out of 4,714 analysts
8
Total ratings
14.29%
Success rate
-21.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Zhiqiang Shu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDYA IDEAYA Biosciences | Initiates: Buy | $26 | $25.69 | +1.21% | 1 | Mar 23, 2023 | |
| KRON Kronos Bio | Initiates: Buy | $12 | $0.97 | +1,135.46% | 1 | Sep 14, 2022 | |
| BPMC Blueprint Medicines | Initiates: Buy | $90 | $89.54 | +0.51% | 1 | Sep 14, 2022 | |
| STRO Sutro Biopharma | Initiates: Buy | $30 | $2.04 | +1,370.59% | 1 | Nov 17, 2021 | |
| SNSE Sensei Biotherapeutics | Downgrades: Hold | $12 | $0.53 | +2,179.64% | 1 | Jul 1, 2021 | |
| NRIX Nurix Therapeutics | Initiates: Buy | n/a | $19.22 | - | 1 | Apr 14, 2021 | |
| STTK Shattuck Labs | Initiates: Buy | $47 | $1.27 | +3,600.79% | 1 | Apr 14, 2021 | |
| RPTX Repare Therapeutics | Initiates: Buy | $51 | $1.38 | +3,595.65% | 1 | Mar 1, 2021 |
IDEAYA Biosciences
Mar 23, 2023
Initiates: Buy
Price Target: $26
Current: $25.69
Upside: +1.21%
Kronos Bio
Sep 14, 2022
Initiates: Buy
Price Target: $12
Current: $0.97
Upside: +1,135.46%
Blueprint Medicines
Sep 14, 2022
Initiates: Buy
Price Target: $90
Current: $89.54
Upside: +0.51%
Sutro Biopharma
Nov 17, 2021
Initiates: Buy
Price Target: $30
Current: $2.04
Upside: +1,370.59%
Sensei Biotherapeutics
Jul 1, 2021
Downgrades: Hold
Price Target: $12
Current: $0.53
Upside: +2,179.64%
Nurix Therapeutics
Apr 14, 2021
Initiates: Buy
Price Target: n/a
Current: $19.22
Upside: -
Shattuck Labs
Apr 14, 2021
Initiates: Buy
Price Target: $47
Current: $1.27
Upside: +3,600.79%
Repare Therapeutics
Mar 1, 2021
Initiates: Buy
Price Target: $51
Current: $1.38
Upside: +3,595.65%